Impax Asset Management Group plc Cuts Stock Position in TriMas Corporation $TRS

Impax Asset Management Group plc trimmed its position in shares of TriMas Corporation (NASDAQ:TRSFree Report) by 20.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 230,000 shares of the industrial products company’s stock after selling 60,000 shares during the quarter. Impax Asset Management Group plc owned 0.57% of TriMas worth $8,887,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. State of Alaska Department of Revenue purchased a new position in shares of TriMas in the third quarter valued at approximately $65,000. State of Wyoming purchased a new position in TriMas in the 2nd quarter valued at approximately $65,000. BNP Paribas Financial Markets boosted its position in TriMas by 35.4% in the 2nd quarter. BNP Paribas Financial Markets now owns 3,319 shares of the industrial products company’s stock valued at $95,000 after buying an additional 868 shares during the period. USA Financial Formulas acquired a new position in shares of TriMas in the third quarter worth $111,000. Finally, Tower Research Capital LLC TRC increased its position in shares of TriMas by 280.5% during the second quarter. Tower Research Capital LLC TRC now owns 4,193 shares of the industrial products company’s stock worth $120,000 after acquiring an additional 3,091 shares during the period. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently commented on TRS. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a research note on Monday, December 29th. Zacks Research downgraded TriMas from a “strong-buy” rating to a “hold” rating in a research report on Thursday, December 11th. BWS Financial restated a “buy” rating and set a $45.00 target price on shares of TriMas in a research note on Friday, December 5th. Wall Street Zen downgraded shares of TriMas from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Finally, KeyCorp lowered their price target on shares of TriMas from $45.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, TriMas presently has a consensus rating of “Moderate Buy” and an average target price of $41.50.

Check Out Our Latest Analysis on TriMas

TriMas Stock Performance

NASDAQ TRS opened at $36.01 on Thursday. The company has a fifty day moving average of $34.89 and a two-hundred day moving average of $35.83. The company has a market capitalization of $1.46 billion, a PE ratio of 33.34 and a beta of 0.57. TriMas Corporation has a 1 year low of $19.33 and a 1 year high of $40.34. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.42.

TriMas Profile

(Free Report)

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.

Read More

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.